Hesperion announces the opening of its Russian Moscow Office
Hesperion Ltd, a fully owned subsidiary of Cerep SA announced the opening of its Russian Moscow Office. Located in Orbita Technopark Business Center, the opening of Hesperion Russia is a step in the continued expansion of Hesperion Ltd within Eastern Europe. Hesperion's presence in Moscow shall greatly increase its attractiveness to sponsors wishing to conduct global studies requiring large patient populations.
Hesperion Russia is in possession of an extensive database of investigational sites stretching from the European part of Russia to Siberia and the Far East. The new office is staffed by highly experienced local CRAs all of whom are medical doctors specializing in cardiology, oncology, endocrinology, gastroenterology, pediatrics, gynecology, and psychiatry. The Hesperion Russian office will provide the complete range of CRO services, in addition to specialized facilities necessary owing to the special nature of legal and regulatory requirements in Russia. Hesperion Russia is unique in that it has its own fully equipped medication and clinical trial materials storage facilities. An important extra service offered is that of registration of the new medical remedies on the Russian market. Hesperion Moscow is a fully owned subsidiary of Hesperion Ltd.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
